Early diagnosis and treatment of pancreatic cancer offer the best odds of beating the disease. Unfortunately, there is still no screening test, such as a blood test, that can reliably detect ...

Pancreatic ductal adenocarcinoma (PDAC) is associated with several genetic syndromes. However, the molecular mechanism underlying PDAC progression is still unknown. In this study, we showed that ...

Vincent Picozzi, MD, discusses findings from the phase 3 trial PANOVA-3 of TTFields with gemcitabine and nab-paclitaxel in locally advanced pancreatic cancer.

Bridge Institute of Experimental Tumour Therapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, 47057 Essen, Germany Division of Solid Tumour Translational ...

In an interview, Arvind Bussetty, MD, and Arvind Trindade, MD, delved into the rising rates of gastrointestinal cancers among ...

Endoscopic ultrasound (EUS)-guided ... than surgical pathology (high-grade dysplasia cannot exclude adenocarcinoma). The EUS-FNB/TTNB methods complement EUS-FNA cytology in diagnosing pancreatic ...

Pancreatic ductal adenocarcinoma (PDAC) accounts for more than 90% of cases of pancreatic cancer, and prognosis for PDAC remains poor despite treatment advances. One reason is that PDAC downregulates ...

Background and Aims: Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is a safe and accurate technique for diagnosing pancreatic cancer. The value of repeat EUS-FNA in patients with ...

In this work, the effect of simultaneous exposure of low-intensity pulsed ultrasound and static magnetic field on colon (HCT116) and hepatocellular (HepG2) carcinoma cell inhibition was assessed in ...

aDepartment of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany bDepartment of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany mDepartment of Gastroenterology, ...